Literature DB >> 30599861

A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters.

Mahrooz Malek1, Masoumeh Gity1, Azadeh Alidoosti2, Zeinab Oghabian3, Pariya Rahimifar1, Seyede Mahdieh Seyed Ebrahimi1, Elnaz Tabibian1, Mohammad Ali Oghabian3.   

Abstract

PURPOSE: To propose a computer-assisted method for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted magnetic resonance imaging (PWI).
MATERIALS AND METHODS: Forty-two women confirmed to have a total of 60 masses (10 uterine sarcomas and 50 benign leiomyomas) were included. The reference diagnosis was based on postoperative histopathological examination. All women underwent the standard MRI protocol with 3-Tesla MR imager (Magnetom Trio, Siemens, Erlangen, Germany) for assessment of myometrial masses, followed by PWI. For each mass, two regions of interest (ROI) were outlined manually by an experienced radiologist; one (ROIL) represented the entire tumor while the other (ROIs) was placed on the area of the lesion with the most marked contrast enhancement. Two additional ROIs with diameters similar to ROIs (3.0 to 3.1 mm) were placed on psoas muscle (ROIP) and myometrium (ROIM) in order to provide baselines for comparisons. The obtained ROIs of PWI images were then analyzed using the DCE Tool plug-in (version 2.0SP1) within ClearCanvas (Toronto, Ontario, Canada) framework. The DCE Tool provides seven parameters (Ktrans, kep, Vb, IAUC, initial slope, peak, the mean squared error) for modelling contrast uptake within an ROI using the modified Tofts model. Parameters extracted from the ROIs were fed into a decision tree ensemble, which classified the corresponding lesions either as malignant or benign. The leave-one-out cross validation (LOOCV) was utilized to evaluate the performance of the classifier.
RESULTS: None of the parameters extracted from ROIL or ROIs differed significantly between uterine sarcoma and benign leiomyomas (all p > 0.05). The overall accuracy of 66.7% was obtained by feeding seven parameters extracted from ROIL to the classifier. When 21 features extracted from ROIL, ROIM, and ROIP were fed into the classifier an accuracy of 91.7%, sensitivity of 100%, and specificity of 90% were achieved in the optimal operating point of classifier.
CONCLUSION: Although none of the PWI parameters differed significantly between benign and malignant lesions, when the information provided by the extracted features was aggregated using a machine learning method, a promising discriminative power was obtained. This suggests that the proposed model for combining the PWI parameters is potentially useful for differentiating uterine sarcoma from leiomyomas.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Computer-aided diagnosis; Leiomyomas; Magnetic resonance imaging; Perfusion weighted imaging; Uterine sarcoma

Mesh:

Year:  2018        PMID: 30599861     DOI: 10.1016/j.ejrad.2018.11.009

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

Review 1.  Advances in the Preoperative Identification of Uterine Sarcoma.

Authors:  Junxiu Liu; Zijie Wang
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

Review 2.  Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions.

Authors:  Klaudia Żak; Bartłomiej Zaremba; Alicja Rajtak; Jan Kotarski; Frédéric Amant; Marcin Bobiński
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

3.  Classification of malignant tumors by a non-sequential recurrent ensemble of deep neural network model.

Authors:  Dipanjan Moitra; Rakesh Kr Mandal
Journal:  Multimed Tools Appl       Date:  2022-02-14       Impact factor: 2.577

Review 4.  Artificial intelligence: A rapid case for advancement in the personalization of Gynaecology/Obstetric and Mental Health care.

Authors:  Gayathri Delanerolle; Xuzhi Yang; Suchith Shetty; Vanessa Raymont; Ashish Shetty; Peter Phiri; Dharani K Hapangama; Nicola Tempest; Kingshuk Majumder; Jian Qing Shi
Journal:  Womens Health (Lond)       Date:  2021 Jan-Dec

5.  A meta-analysis of Watson for Oncology in clinical application.

Authors:  Zhou Jie; Zeng Zhiying; Li Li
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

Review 6.  Progress of Artificial Intelligence in Gynecological Malignant Tumors.

Authors:  Jie Zhou; Zhi Ying Zeng; Li Li
Journal:  Cancer Manag Res       Date:  2020-12-14       Impact factor: 3.989

Review 7.  New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions.

Authors:  Pamela Causa Andrieu; Sungmin Woo; Tae-Hyung Kim; Elizabeth Kertowidjojo; Anjelica Hodgson; Simon Sun
Journal:  Curr Opin Oncol       Date:  2021-09-01       Impact factor: 3.915

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.